Sean P. Nolan

Filings by Sean P. Nolan span 3 companies, the busiest being AveXis, Inc., Taysha Gene Therapies, Inc. and Ventas, Inc. We count 26 filings; the first trade dates from 7 March 2018 and the latest from 13 May 2026.

Market trades split into 2 purchases (€389k) and 8 sales (€1.8M). Taken together, the sales exceed the purchases by €1.4M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 12 share grants and 1 option exercise. So far in 2026, the count stands at no purchases and 2 sales.

The newest entry dates from 15 May 2026: a share grant of €158k, in Ventas, Inc. The last insider purchase was made public on 16 August 2023, 1,165 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.